Priming With tDCS: Expanding the Window of Recovery in Chronic Stroke
Investigation of Central Priming Prior to Training of the Upper Extremity in Chronic Stroke
1 other identifier
interventional
14
1 country
1
Brief Summary
Stroke often leads to long-term disability including upper extremity (UE) dysfunction even with the provision of timely rehabilitation services. Brain injury stemming from stroke, affecting the corticospinal system results in weakness, alterations in muscle tone and incoordination during the performance of functional tasks. Recovery of functional task performance after injury to the corticospinal system involves a residual neural network that engages the premotor cortex, frontal cortex and supplementary motor cortex. In particular, the dorsal premotor cortex (PMd) is anatomically and physiologically poised to reorganize and support motor recovery after corticospinal damage. The goal of this study is to determine the feasibility and efficacy of stimulating the ipsilesional PMd in adults with chronic stroke using noninvasive anodal transcranial direct current stimulation (tDCS) during the training sessions of a 4-week circuit-based, UE, task-related training (TRT) program. Pilot data from six adults, using anodal tDCS over the injured PMd just before each session of TRT, led to significant improvements in UE function in 5 of the 6 adults after only 4 weeks of training. We will assess the motor function of both arms using clinical assessments immediately before and after the 4-week TRT program. In addition to effects of tDCS-primed UE-TRT on clinical outcomes, we will use functional magnetic resonance imaging (fMRI) to determine the changes in neural network reorganization. We hypothesize that the training program will reveal significant improvement in motor function based on clinical assessment as well as significant global network changes based on resting state functional MRI and hybrid diffusion MR imaging. The long-term goal of this research is to develop an effective intervention strategy to improve UE function in individuals with moderate impairment from chronic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2019
CompletedFirst Submitted
Initial submission to the registry
May 22, 2019
CompletedFirst Posted
Study publicly available on registry
May 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2023
CompletedFebruary 6, 2023
February 1, 2023
4.2 years
May 22, 2019
February 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
UE Accelerometry
actigraph markers placed on each arm
3 day period prior to training
UE Accelerometry
actigraph markers placed on each arm
3 day period post training to assess change- more activity inbdicates greater overall use
Functional MRI
fMRI consisting of structural data collected, DTI, resting state data functional task data
within 3 days prior to training
Functional MRI
fMRI consisting of structural data collected, DTI, resting state data and functional task data
within 3 days post training to measure change- increased activity in designated areas explains pattern of neuroplasticity
Secondary Outcomes (10)
Body Structure Function and Impairment Data
1-3 days prior to training start
Body Structure Function and Impairment Data
1-3 days post training
Body Structure Function and Impairment Data
1-3 days prior to training start
Body Structure Function and Impairment Data
1-3 days post training
Body Structure Function and Impairment Data
1-3 days prior to training start
- +5 more secondary outcomes
Study Arms (2)
Experimental
EXPERIMENTALTranscranial Direct Current Stimulation.1) Scalp measurements of the scalp will be taken using the 10-20 EEG measurement system to determine anode and cathode placement. 2) One 1x1 Bicarbon electrode with wires attached will be placed in the center of each 5 cm x 7 cm sponge electrode dampened with 8 ml of saline. 3) One sponge electrode will be placed over the ipsilesional PMd (F3) and the other sponge electrode over the contralesional supraorbital region(Fp2). 4) Each sponge electrode will be secured under the plastic EZ strap 5) The current from the Actividose II will be turned up to 2 MA. The current will ramp up/down in 15 seconds. We will observe for adverse effects and hit the pause button, then turn the machine off, if a participant does not tolerate the stimulation. Individuals in this arm will have the stimulation stay in current until the full dose is delivered. Each participant will then engage in the UE TRT as outlined below.
Control
SHAM COMPARATORIndividuals in this arm will have the stimulation cycled off after 2-3 minutes. All will be part of the Circuit-Based, UE Task Related Training. Each participant will engage in the training program for 1.5 hours; rotating through 5 stations at about 15 minute intervals, participating in standing as tolerated, but stations can be adapted to sitting. The goal is for each participant perform \> 225 movements with the affected arm per session, at the highest functional level. Rest breaks given as needed. Examples of stations are: Reach-to-grasp tasks to objects of various weight, texture and dimension at different distances and table heights. Practice opening simulated locks and containers. Shoulder wheel involving grasping plastic plates with varied grip patterns and sliding them up and over the wheel from the unaffected to the affected side encouraging shoulder abduction, external rotation and supination. Bimanual/unimanual ball toss: catching, releasing.
Interventions
see arm/group descriptions
Eligibility Criteria
You may qualify if:
- \> 18-75 years of age;
- diagnosis of ≥ 1 stroke \> 6 months before participation;
- in good health;
- classified with moderate impairment based on the UE Fugl Meyer Assessment (FMA; score of 19-47
- safe for the MRI environment;
- able to elevate and hold the paretic arm for 2 seconds at 90 degs shoulder elevation, 160-180O elbow extension and neutral forearm supination;
- ≥ 20 degrees gravity minimized wrist extension while holding a cylindrical object on a tabletop.
You may not qualify if:
- bone or joint limitations that restrict paretic arm motion;
- history of skull fractures or burr hole(s);
- resting heart rate and resting blood pressure outside the range of 40-100 beats/min and 90/60 to 170/90 mm Hg respectively;
- chest pain or shortness of breath at rest;
- history epilepsy or seizures;
- Botox injections to the paretic arm within 4 months of participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of the Sciences in Philadelphialead
- Chapman Universitycollaborator
- Moss Rehabilitation Research Institutecollaborator
- Thomas Jefferson Universitycollaborator
Study Sites (1)
University of the Sciences
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Thielman, EdD
Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- PI is only doing the testing, while the trainers are training all the participants
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Therapy and Neuroscience
Study Record Dates
First Submitted
May 22, 2019
First Posted
May 28, 2019
Study Start
January 14, 2019
Primary Completion
April 14, 2023
Study Completion
April 14, 2023
Last Updated
February 6, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- as requested and up to 5 years
all fMRI data will be made available to the ENIGMA Stroke group as a member of this consortium. The behavioral data is available publicly as able on this or any site I am directed to. Often I am contacted individually by the PI of systematic reviews for this type of data